CLEAR: lenvatinib and pembrolizumab efficacy in aRCC across baseline tumor sizes VJOncology 2:08 6 months ago 180 Скачать Далее
CLEAR: lenvatinib and pembrolizumab in advanced renal cell carcinoma VJOncology 0:49 1 year ago 1 020 Скачать Далее
Lenvatinib plus pembro for aRCC - update on the CLEAR study ecancer 2:06 1 year ago 386 Скачать Далее
Combining lenvatinib & pembrolizumab for non-clear cell RCC: KEYNOTE-B61 study rationale VJOncology 0:59 1 year ago 198 Скачать Далее
Assessing lenvatinib with pembrolizumab in advanced renal cell carcinoma VJOncology 1:44 6 months ago 158 Скачать Далее
Lenvatinib and Pembrolizumab Compared to Sunitinib for Advanced Renal Cell Carcinoma PracticeUpdate 10:06 3 years ago 821 Скачать Далее
KEYNOTE-B61: first-line lenvatinib + pembrolizumab in non-clear cell RCC VJOncology 1:28 1 year ago 117 Скачать Далее
Lenvatinib Pembrolizumab in RCC, the CLEAR trial with Karine Tawagi Vinay Prasad MD MPH 32:46 3 years ago 1 750 Скачать Далее
CLEAR and Navigating the Frontline Combination Approaches for Advanced RCC GU Oncology Now 5:37 6 months ago 54 Скачать Далее
Discussing the Phase II Study of Lenvatinib/Pembrolizumab in Metastatic ccRCC Targeted Oncology 1:22 4 years ago 485 Скачать Далее
Health-Related Quality of Life With Lenvatinib Plus Pembrolizumab for Patients With Advanced RCC PracticeUpdate 7:05 2 years ago 159 Скачать Далее
Lenvatinib Plus Pembrolizumab After Progression on Immune Checkpoint Inhibitors for Metastatic RCC PracticeUpdate 5:14 3 years ago 274 Скачать Далее
KEYNOTE-B61: Putting a Focus on Non-Clear Cell RCC Treatment GU Oncology Now 5:00 1 year ago 98 Скачать Далее
TKI/IO Comparison: Lenvatinib/Pembrolizumab vs Cabozantinib/Nivolumab vs Axitinib/Pembrolizumab GU Oncology Now 8:07 1 year ago 965 Скачать Далее
Comparison of Frontline Renal Cell Carcinoma Treatment Options GU Oncology Now 8:50 1 year ago 969 Скачать Далее
